single nucleotide variant | NM_000159.4(GCDH):c.262C>A (p.Arg88Ser) | GCDH | Pathogenic/Likely pathogenic | 19 | 13002779 | 13002779 | C | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA305500199 |
single nucleotide variant | NM_000159.4(GCDH):c.268G>A (p.Glu90Lys) | GCDH | Likely pathogenic | 19 | 13002785 | 13002785 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA305500200 |
single nucleotide variant | NM_000159.4(GCDH):c.271+1G>A | GCDH | Pathogenic/Likely pathogenic | 19 | 13002789 | 13002789 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA274289 |
single nucleotide variant | NM_000159.4(GCDH):c.272-2A>C | GCDH | Likely pathogenic | 19 | 13002928 | 13002928 | A | C | criteria provided, multiple submitters, no conflicts | - |
single nucleotide variant | NM_000159.4(GCDH):c.281G>A (p.Arg94Gln) | GCDH | Pathogenic/Likely pathogenic | 19 | 13002939 | 13002939 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA9234312 |
single nucleotide variant | NM_000159.4(GCDH):c.281G>T (p.Arg94Leu) | GCDH | Pathogenic/Likely pathogenic | 19 | 13002939 | 13002939 | G | T | criteria provided, multiple submitters, no conflicts | ClinGen:CA404315814 |
single nucleotide variant | NM_000159.4(GCDH):c.301G>A (p.Gly101Arg) | GCDH | Pathogenic/Likely pathogenic | 19 | 13002959 | 13002959 | G | A | criteria provided, multiple submitters, no conflicts | - |
Deletion | NM_000159.4(GCDH):c.329_332del (p.Ile110fs) | GCDH | Pathogenic/Likely pathogenic | 19 | 13002986 | 13002989 | CATCA | C | criteria provided, multiple submitters, no conflicts | ClinGen:CA658684222 |
single nucleotide variant | NM_000159.4(GCDH):c.334G>T (p.Gly112Ter) | GCDH | Pathogenic/Likely pathogenic | 19 | 13002992 | 13002992 | G | T | criteria provided, multiple submitters, no conflicts | - |
single nucleotide variant | NM_000159.4(GCDH):c.337T>C (p.Tyr113His) | GCDH | Pathogenic/Likely pathogenic | 19 | 13004299 | 13004299 | T | C | criteria provided, multiple submitters, no conflicts | - |